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Summary 
 
Background 
The best initial approach to advanced airway management during out of hospital cardiac arrest 
(OHCA) is unknown. The traditional role of tracheal intubation has been challenged by the 
introduction of supraglottic airway devices (SGAs), but there is contradictory evidence from 
observational studies. We assessed the feasibility of a cluster-randomised trial to compare the i-gel 
SGA versus the laryngeal mask airway supreme (LMAS) versus current practice during OHCA.   
Methods 
Cluster-randomised trial in a single ambulance service in England, with individual paramedics as the 
unit of randomisation. Consenting paramedics were randomised to use either the i-gel or the LMAS 
or usual practice for all cases of non-traumatic adult OHCA that they attended over a 12-month 
period.  The primary outcome was study feasibility, including paramedic and patient recruitment and 
protocol adherence. Secondary outcomes included survival to hospital discharge and 90 days.   
Results 
Of the 535 paramedics approached, 184 consented and 171 attended study training. Each paramedic 
attended between 0 and 11 patients (median 3; interquartile range 2-5). We recruited 615 patients 
at a constant rate, although the LMAS arm was suspended in the final two months following three 
adverse incidents. The study protocol was adhered to in 80% of cases. Patient characteristics were 
similar in the three study arms, and there were no differences in secondary outcomes.      
Conclusions 
We have shown that a prospective trial of alternative airway management strategies in OHCA, 
cluster randomised by paramedic, is feasible.  
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Introduction 
In the United Kingdom (UK) there are 118 out of hospital cardiac arrests (OHCAs) per 100,000 
population per annum,1 and the UK ambulance service attends 60,000 such patients each year.2 
Approximately 7% survive to hospital discharge.3  
Immediate cardiopulmonary resuscitation (CPR) following cardiac arrest improves survival rates.4 
Effective ventilation is an essential component of CPR,5 and is associated with both return of 
spontaneous circulation (ROSC) and neurological recovery.6  However, what constitutes effective 
ventilation is uncertain.7   
Traditionally, tracheal intubation has been viewed as the best airway management during OHCA.8 
However, this assumption has never been tested prospectively,9 and pre-hospital intubation 
attempts by paramedics are associated with important complications: interruptions in chest 
compressions, unrecognised oesophageal intubation (particularly when end-tidal carbon dioxide 
monitoring is not used), compromised oxygenation and delays in accessing definitive care.10 11   
 
Supraglottic airway devices (SGAs) are an alternative to intubation. They are faster and easier to 
insert and may reduce the complications associated with tracheal intubation.12 SGAs are used safely 
and effectively in many hospital procedures;13-15 however their safety and efficacy out of hospital has 
not been well studied.  The risk of regurgitation is higher during OHCA,16 17 and SGAs may dislodge 
more frequently than tracheal tubes.  
 
The Joint Royal Colleges Ambulance Liaison Committee (JRCALC) has recommended that ambulance 
services in the UK consider SGAs as an alternative to tracheal intubation.18  SGAs are now used 
routinely in many UK ambulance services.19  The 2013/14 London Ambulance Service report 
documented 1354/1637 (82.7%) successful OHCA intubations and 2674/2954 (90.5%) successful SGA 
placements.20  
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Equipoise between the two techniques has led to calls for a large randomised clinical trial (RCT) 
comparing SGAs with tracheal intubation.21 22 However, such a trial is both logistically and ethically 
challenging, with considerable uncertainty as to whether it could be completed successfully. Some 
previous randomised trials involving paramedics have been unsuccessful as a result of poor 
compliance and patient crossover,23 and no randomised trial of tracheal intubation versus SGAs has 
ever been completed in cardiac arrest.  Furthermore, several SGAs are available, but the optimal 
device during OHCA is unknown. Therefore, before proceeding to a large-scale and costly 
randomised trial, recruiting many thousands of patients, it was necessary to demonstrate that our 
proposed study design was feasible, to develop and refine the methodology and identify the optimal 
SGA for use in subsequent research.  
Our hypothesis was that a cluster randomised trial to compare the ventilation success of two SGAs 
to usual practice during the initial airway management of OHCA in an English ambulance service is 
feasible. Our primary objective was therefore to assess the feasibility of a prospective cluster 
randomised trial to compare the ventilation success of two second generation SGAs: the i-gel 
(Intersurgical; Wokingham, UK) and the laryngeal mask airway supreme (LMAS) (LMA/Teleflex; San 
Diego, USA) to usual practice (principally tracheal intubation), as the initial approach to advanced 
airway management during OHCA. The secondary objectives were to estimate the intra-class 
correlation coefficient for paramedic clusters to establish the variance arising from a cluster 
randomised design, and to describe the clinical outcomes of the i-gel versus LMAS versus current 
practice during the initial management of OHCA, in terms of insertion and ventilation success, return 
of spontaneous circulation (ROSC), survival to hospital discharge, and survival, neurocognitive 
function and quality of life 90 days after OHCA.  
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Methods 
The study methods have been described previously.24 In summary, we completed a feasibility study, 
using a cluster randomised design, to compare the initial use of the i-gel and LMAS with current 
practice during resuscitation for OHCA.  The study setting was a single ambulance service in 
Southwest England, covering an urban and semi-rural population of approximately 2 million people.  
Randomisation 
We chose a cluster randomised design because an individually randomised design would require 
participating paramedics to carry and use all devices, increasing the risk that they would not use the 
device to which a patient had been allocated. It is also logistically challenging to randomise 
individual patients during the initial management of OHCA, when immediate patient care and 
effective CPR is the priority. 
We therefore selected cluster randomisation by paramedic, seeking volunteers from the Great 
Western Ambulance Service NHS Trust (now South Western Ambulance Service NHS Foundation 
Trust: SWAST). Paramedics were eligible if they were engaged in regular operational duties, were 
not employed in a specialist role and volunteered to take part. Participating paramedics were 
randomly allocated to one of the three study arms (i-gel, LMAS or current practice) through an 
independent computer-generated process undertaken by the trial statistician, and with full 
concealment. Randomisation was stratified by years of operational experience (< 4 years, or > 4 
years full time experience) and by rural or urban location of the paramedic’s base ambulance 
station.   
Paramedic Training 
Following written informed consent participating paramedics were invited to attend a structured 
training session lasting 120 minutes: 60 minutes of generic training on resuscitation, airway 
management and trial procedures, and an additional 60 minutes of airway training specific to the 
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study arm, with competence confirmed through the administration of a brief standardised verbal 
and practical assessment.  Paramedics randomised to the i-gel or LMAS arms were issued with a 
personal supply of the relevant device, and were required to account for each use. Paramedics 
randomised to routine care were instructed to continue with their normal practice, which included 
the choice of bag-mask ventilation, a single-use disposable Laryngeal Mask Airway (AMBU Auraonce; 
Ballerup, Denmark) or tracheal intubation.  
Patient Eligibility 
 
Patients were eligible for enrolment in the study if they were  in cardiac arrest outside hospital, 
attended by a paramedic enrolled in the trial, attempted resuscitation was deemed appropriate 
according to Joint Royal Colleges Ambulance Liaison Committee (JRCALC) guidelines, and the patient 
was known or believed to be 18 years or older.  
 
Exclusion criteria were cardiac arrest caused by trauma, estimated patient weight less than 50 kg,  
mouth opening less than 2 cm, patient detained by Her Majesty’s Prison Service, or previously 
recruited to the same study. 
 
The first paramedic participating in the study to arrive on scene determined the allocation of the 
patient, with analysis undertaken on an intention to treat basis. 
 
Blinding 
Because of the nature of the intervention, ambulance clinicians could not be blinded.  Control room 
personnel were blinded to the allocation of paramedics, which ensured there was no bias in 
dispatch. Patients were unaware of their allocation throughout the trial. Outcome assessment was 
carried out by an individual blinded to study allocation.  
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Study Procedures 
Participating paramedics were instructed to deliver standard resuscitation protocols to all patients in 
accordance with Resuscitation Council (UK) guidelines, with the exception that the allocated 
approach to initial airway management was used whenever possible.  
For the i-gel and LMAS arms, the SGA was inserted at the first opportunity without interrupting 
cardiopulmonary resuscitation (CPR), and an attempt made to ventilate the lungs at a rate of 
approximately 10 breaths a minute while compressions were ongoing. If ventilation was deemed 
inadequate (no chest rise observed), chest compressions were paused to enable ventilation of the 
lungs using a chest compression to ventilation ratio of 30:2.  
The SGAs were inserted according to the manufacturer’s instructions.  Paramedics made a maximum 
of three attempts to place their allocated SGA, and were instructed to take no more than 30 seconds 
for each attempt. If a paramedic was unsuccessful at the third attempt, they switched to whatever 
alternative technique they deemed to be in the best interests of the patient. 
Adequate ventilation with a device was defined as visible chest rise with each breath. To ensure that 
all eligible OHCA patients were included in the study daily searches of the ambulance computer-
aided despatch (CAD) system were undertaken to identify possible OHCAs, and the study records 
were regularly reconciled with routinely collected data relating to all OHCA patients. At the end of 
the trial all SGAs were collected and accounted for, to ensure that no device was used outside the 
study protocol. 
Sample Size Calculation 
In this feasibility study a formal calculation of power was not carried out, but an analysis of the 
expected number of paramedics who would attend two or more eligible events in a 12-month period 
was completed, estimating the events to occur randomly throughout the sample and following a 
Poisson distribution. This indicated that 7% of paramedics would not be expected to attend any 
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suitable patients in 12 months, and 10% would attend only one event. Therefore, in order to ensure 
that at least 30 paramedics in each arm attended at least two events, and to allow for some 
paramedics drop out, we aimed to recruit 50 paramedics to each trial arm. 
Clinical Outcome Measures 
Return of spontaneous circulation (ROSC) was reported by participating paramedics, and confirmed 
by review of hospital notes. Survival to hospital admission and survival to hospital discharge were 
confirmed by review of hospital notes, and by direct contact with the patient or their consultee 
during the consent process. Survival to 90 days following OHCA was confirmed by contact with the 
patient’s general practitioner, prior to follow-up data collection by a researcher, blinded to 
treatment allocation, in the patient’s home.  
At 90 days the Cambridge neuropsychological test automated battery (CANTAB) was administered: a 
computerised touch-screen system that objectively measures a range of cognitive functions.25 This 
tool has been previously used to assess cognitive function in OHCA survivors.26 The Delayed 
Matching to Samples (DMS) test was chosen to assess short-term recognition memory. The total 
correct responses and correct responses on the 0 and 12s delay conditions were reported.26 Quality 
of life (QoL) in survivors was measured using the Depression, Anxiety and Stress Scale and the Short 
Form-36 (SF-36) questionnaire.27 28  
Ethical Considerations 
OHCA is unpredictable. Within seconds of cardiac arrest a person becomes unconscious and thus 
incapacitated. In this situation it is impractical to consult another person without placing the 
potential participant at risk of harm from delaying treatment.  Therefore, it was not possible to seek 
consent before enrolment and intervention, and an OHCA patient was considered to have been 
enrolled in the trial at the time of their cardiac arrest if they met the eligibility criteria and were 
attended by a participating paramedic. Consent to continue with follow-up was sought from 
11 
 
surviving patients once they had regained capacity in hospital. Alternatively, if the patient survived 
but did not have capacity, an opinion was sought from a consultee.  
We did not seek to inform the relatives of patients who died soon after OHCA.  Our patient forum 
was of the view that to inform relatives of the study, following a very recent bereavement, would 
serve no useful purpose and would only lead to unnecessary distress.   
These processes were approved by the Cambridge Central NHS Research Ethics Committee, which 
has specific expertise in trials of medical devices in incapacitated adults. 
The trial was registered (ISRCTN: 18528625). The contribution of the manufacturers of the SGAs was 
limited to confirming that the training of paramedics in the use of the devices conformed to their 
recommended guidelines. These manufacturers had no role in supplying devices or the design, 
funding, conduct, analysis or reporting of the trial. 
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Results 
Of 535 eligible paramedics, 212 (40%) expressed an interest and 184 (35%) consented to participate. 
171 (32%) attended training and were eligible to enrol patients, with 9 of these withdrawing during 
the study. Reasons for withdrawal were: maternity leave (5); leaving the employing ambulance 
service (2); long-term sick leave (1); no reason given (1). 
The number of eligible patients attended by each participating paramedic over 12 months ranged 
from 0 to 11.  The median was 3 (interquartile range 2 to 5), and 9% of paramedics attended no 
OHCA patients. The intra-class correlation coefficient (ICC) for the outcome of survival to discharge 
by paramedic clusters was <0.001 (95% CI, 0.00 - 0.065), indicating very little variance attributable to 
the cluster randomised design. 
During the 12-month study period 2,990 cardiac arrests occurred in the participating ambulance 
service, of which 2,375 (79%) were not eligible for inclusion. A CONSORT diagram is shown in Figure 
1. By far the commonest reason for non-eligibility was no active resuscitation attempt, (1,615 
patients; 54%). All eligible patients (n = 615) were enrolled and analysed on an intention to treat 
basis.  
The total number of patients enrolled in each study arm was: i-gel 232 (38%); LMAS 174 (28%); usual 
practice 209 (34%). The LMAS arm was discontinued after 10 months because on three occasions 
ambulance staff were contaminated by blood and vomit ejected forcefully from the gastric drainage 
port of the LMAS during CPR. Otherwise, recruitment to the three trial arms was consistent 
throughout the study.  
Protocol adherence by trial arm is shown in Table 1. Overall, the study protocol was adhered to in 
80% of cases. In 16% the patient received no advanced airway management (often for legitimate 
reasons such as rapid early recovery) or the incorrect device initially, and in 4% of patients these 
data were missing. 
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Baseline characteristics for the three trial arms are shown in Table 2. First attempt placement 
success for the i-gel was 79% (unable to insert: 4%, inadequate ventilation: 17%) and for the LMAS 
was 75% (unable to insert: 4%, inadequate ventilation: 21%). Overall, tracheal intubation was 
attempted in 46% of enrolled patients (267/584), and was successful on the first attempt in 85%. 
Other clinical outcomes, including survival to hospital discharge and survival to 90 days, are shown in 
Table 3. Neurocognitive outcomes are shown in Table 4, and quality of life outcomes are shown in 
Table 5.  
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Discussion 
We have demonstrated that it is possible to complete a randomised trial of alternative airway 
management strategies during OHCA, successfully recruiting and randomising paramedics and 
enrolling and following-up patients. Recruitment of both paramedics and patients exceeded our pre-
determined targets, and there was consistent recruitment with good protocol compliance.  We did 
not show a difference in survival, neurocognitive function or quality of life between the three study 
arms, but the study was not powered sufficiently to detect clinically significant differences in these 
secondary outcomes. 
Initial airway management is one of the most controversial aspects of OHCA. Registry data have 
demonstrated an association between bag-mask ventilation and improved outcomes when 
compared with both SGAs and tracheal intubation,29-32 whereas a recent meta-analysis has shown 
that tracheal intubation was associated with better outcomes than SGAs.33   
Paramedic dropout was around 5% per year, and the intra-class correlation coefficient (ICC) for 
paramedic clusters had a value of <0.001, which means that the variability between paramedics was 
low compared with the variability between the patients treated by a paramedic. This suggests that 
cluster randomisation by paramedic was close to individual patient randomisation, and reflects the 
fact that the number of patients treated by each paramedic was relatively small (median 3).  
Following inadvertent contamination of ambulance staff in three cases, the LMAS arm was 
discontinued after 10 months. These three events were reported as adverse incidents, and also in a 
subsequently published letter.34 The manufacturer of the LMAS responded suggesting that 
ambulance staff should ensure full personal protection, and that ejection of gastric contents 
indicated correct functioning of the device.35  However, confidence in the LMAS was undermined and 
recruitment to this arm of the trial discontinued on the direction of the trial sponsor.  Compliance 
with the LMAS was lower than with the i-gel, and paramedic feedback favoured the i-gel device. 
15 
 
Further evidence of the effective use of the i-gel during OHCA in Europe was published while this 
study was in progress.19 36 We have therefore decided to use the i-gel in future studies.  
We recruited 45% of all eligible patients who underwent resuscitation. No patient was lost to follow 
up, and the arrest characteristics of resuscitated patients who were enrolled and not enrolled in the 
study were very similar (data not shown). The baseline characteristics compared in Table 2 are well 
matched, and suggest that randomisation was effective. The rates of ROSC, hospital admission and 
survival to hospital discharge are similar to those reported from other parts of England.20  
In the SGA groups, the first attempt placement success rate was 79% for the i-gel and 75% for the 
LMAS, which is slightly lower than some previous reports. One study documented a first attempt 
placement success rate of 90% for the i-gel in 70 OHCA patients in Germany (63 paramedics and 7 
doctors).37 Although the training provided in this study was similar to ours, the availability of other 
options is unclear. The only other prospective randomised trial of alternative airway management 
strategies in OHCA compared the i-gel with the Portex Soft Seal Laryngeal Mask (PSS-LM) in a total of 
51 patients in Australia.38 The authors report an insertion success rate of 90% for the i-gel and 57% 
for the PSS-LM (p=0.023), suggesting that the latter device is poorly suited to OHCA. In comparison, 
first pass success rates for the laryngeal tube (LT) have been reported recently as 72% and 83%.39 40 
We documented a first attempt tracheal intubation success rate of 85%. This is comparable with 
other reports of intubation success in cardiac arrest: tracheal intubation was achieved in three or 
fewer attempts in 91% of 628 OHCA patients in a Scottish study.11  
Ongoing uncertainty in this area of practice has led to consistent calls for a RCT to determine which 
advanced airway is best in the initial management of OHCA,15 35 36 and we are now progressing to a 
large-scale RCT of the i-gel versus tracheal intubation.   
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Limitations 
This study has several weaknesses. We designed the study to avoid overlooking any eligible patients, 
and also to minimise bias, but given the cluster randomised design and the complexities of the 
clinical environment we cannot rule out the possibility that a degree of residual bias exists. 
Randomisation by patient would have been preferable, but was judged impractical and potentially 
unethical if it led to delays in care. We recruited only one third of all eligible paramedics, and since 
these were volunteers they may not be representative of the wider paramedic profession. The study 
was completed in a single UK ambulance service, and not all eligible patients were enrolled: 
therefore whilst the characteristics of enrolled and not enrolled patients were similar our results 
may not be generalizable to other regions or countries. The clinical outcomes were collected in an 
independent and blinded fashion, but some of the process outcomes (e.g. first attempt device 
placement success) were self-reported and the paramedics themselves were not blinded. The usual 
practice arm was not standardised, so although this represents a pragmatic comparison it consists of 
a range of practices including bag-mask ventilation alone and the use of a different SGA, as well as 
tracheal intubation. 
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Conclusion 
We have demonstrated that a prospective randomised trial of alternative approaches to advanced 
airway management during adult non-traumatic OHCA is feasible in the UK, through the effective 
engagement of paramedics, and that a high degree of protocol compliance can be achieved. We 
found no differences in survival, neurocognitive function or quality of life between a supraglottic 
airway device and usual practice during OHCA. However the trial was insufficiently powered to 
detect important differences in these clinical outcomes. We are now proceeding to a large-scale RCT 
of the i-gel versus tracheal intubation in OHCA.  
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 Adherent 
n (%) 
Non-adherent 
n (%) 
Missing Data 
n (%) 
i-gel (n = 232) 172 (74) 51 (22) 9 (4) 
LMAS (n = 174) 119 (68) 46 (26) 9 (5) 
Usual practice (n = 209) 198 (95) 3 (1) 8 (4) 
Total (n = 615) 489 (80) 100 (16) 26 (4) 
Table 1: Protocol adherence by trial arm 
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Characteristic i-gel 
(n = 232) 
LMAS 
(n = 174) 
Usual Practice 
(n = 209 ) 
Age: years (mean, median (SD)) 70, 73 (17.1) 71, 74 (15.5) 71, 75 (14.6) 
        
Male: % (n/N) 64.6 (144/223) 61.2 (104/170) 58.6 (119/203) 
        
Presumed cardiac cause: % (n/N) 94.2 (213/226) 97.1 (165/170) 97.1 (200/206) 
        
OHCA at home address: % (n/N) 74.8% (169/226) 71.8% (122/170) 73.8% (152/206) 
        
Witnessed:% (n/N) 32.3% (73/226) 30.0% (51/170) 35.1% (72/205) 
       
Bystander CPR: % (n/N) 46.9% (106/226) 50.6% (86/170) 40.3% (83/206) 
Table 2: Baseline characteristics of three trial arms. SD – standard deviation; LMAS – laryngeal mask 
airway supreme; OHCA – out of hospital cardiac arrest; CPR – cardiopulmonary resuscitation. 
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Outcome i-gel  
% (n/N) 
n = 232 
LMAS 
% (n/N) 
n = 174 
Usual Practice 
% (n/N) 
n = 209 
ROSC on hospital 
arrival 
30.8 
(70/227) 
31.2 
(53/170) 
32.7 
(67/205) 
       
Admission to 
hospital 
 22.0 
(50/227) 
 17.6 
(30/170) 
21.0 
(43/205)  
       
Survival to hospital 
discharge 
10.3 
(24/232) 
8.0 
(14/174) 
9.1 
(19/209) 
       
Survival to 90 days 9.5 
(22/232) 
6.9 
(12/174) 
8.6 
(18/209) 
Table 3: Comparison of the clinical outcomes between the three trial arms. LMAS – laryngeal mask 
airway supreme; ROSC – return of spontaneous circulation. 
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CANTAB DMS i-gel 
mean correct (SD) 
n = 14 
LMAS 
mean correct (SD) 
n = 10 
Usual Practice 
mean correct (SD) 
n = 10 
All Delays 11.8 
(2.4) 
10.7 
(1.6) 
9.9 
(2.0) 
       
0 Second Delay  4.3 
(1.0) 
 4.1 
(1.0) 
3.8 
(1.0)  
       
12 Second Delay 3.4 
(1.5) 
3.2 
(0.9) 
3.0 
(1.3) 
Table 4: Comparison of neurocognitive outcomes between the three trial arms. SD – standard 
deviation; LMAS – laryngeal mask airway supreme; CANTAB - Cambridge neuropsychological test 
automated battery; DMS – delayed matching to samples. The maximum possible score was five for 0 
second delay, five for 12 second delay, and fifteen for all delays. Seven patients declined to 
participate in this part of the study, and one patient with a pre-existing neurological deficit was 
excluded. Seven further patients were excluded from the DMS analyses because they were unable to 
complete the assessment. 
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Quality of Life 
Measure 
i-gel 
mean score 
(SD) 
n = 16 
LMAS 
mean score 
(SD) 
n = 11 
Usual Practice 
mean score 
(SD) 
n = 14 
SF-36 Physical 
Component Score 
 43.9 
(11.4) 
 41.5 
(11.3) 
49.2 
(7.6)  
SF-36 Mental 
Component Score 
47.7 
(11.1) 
50.4 
(8.2) 
46.9 
(13.7) 
Overall Depression, 
Anxiety & Stress 
Scale (DASS) Score 
27.1 
(30.2) 
18.3 
(16.3) 
15.4 
(20.0) 
Table 5: Comparison of quality of life outcomes between the three trial arms. SD – standard 
deviation; LMAS – laryngeal mask airway supreme; SF-36 - Short Form-36. The SF-36 ranges from 0 
(worst health) to 100 (best health). The DASS ranges from 0 (best health) to 42 (worst health). Seven 
patients declined to participate in this part of the study, and one patient with a pre-existing 
neurological deficit was excluded. One further patient was excluded from this analysis because they 
were unable to complete the assessment. 
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Legends for Figures 
 
 
 
Figure 1: CONSORT Diagram. “Other” exclusions were: detained by Her Majesty’s Prison Service (2 
patients); mouth-opening < 2 cm (2 patients); previously recruited to the same study (1 patient). Post 
LMAS (33 patients) refers to those patients who were attended by a paramedic randomised to the 
LMAS arm after that arm was suspended (see text). 
